Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
trospium
Description:
An antimuscarinic medication used to treat overactive bladder by reducing involuntary contractions of the urinary bladder.
Primary topic:
Urinary Bladder and Prostate Research (47%)
Related topics:
Urinary Bladder and Prostate Research (47%),
Schizophrenia research and treatment (26%)
OpenAlex ID:
keywords/trospium
The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis
2008
·
Christopher R. Chapple
, Vik Khullar
, et al.
·
European Urology
·
814
Muscarinic receptor antagonists for overactive bladder
2007
·
Paul Abrams
, Karl‐Erik Andersson
·
British Journal of Urology
·
441
Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia
2021
·
Stephen K. Brannan
, Sharon Sawchak
, et al.
·
New England Journal of Medicine
·
389
PDF
Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience
2012
·
Adrian Wagg
, Gerhard Compion
, et al.
·
British Journal of Urology
·
339
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023
·
Inder Kaul
, Sharon Sawchak
, et al.
·
The Lancet
·
294
Comparative Efficacy and Safety of Medical Treatments for the Management of Overactive Bladder: A Systematic Literature Review and Mixed Treatment Comparison
2013
·
Khaled Maman
, Samuel Aballea
, et al.
·
European Urology
·
271
Muscarinic receptors in the bladder: from basic research to therapeutics
2006
·
Sharath S. Hegde
·
British Journal of Pharmacology
·
258
PDF
Anticholinergic Therapy vs. OnabotulinumtoxinA for Urgency Urinary Incontinence
2012
·
Anthony G. Visco
, Linda Brubaker
, et al.
·
New England Journal of Medicine
·
241
PDF
Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT–PCR: changes in ageing
2005
·
Kylie J Mansfield
, Lu Liu
, et al.
·
British Journal of Pharmacology
·
231
PDF
A comprehensive non‐clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder
2011
·
Ernesto Callegari
, Bimal Malhotra
, et al.
·
British Journal of Clinical Pharmacology
·
192
PDF
Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin
2008
·
G. G. Kay
, U. Ebinger
·
International Journal of Clinical Practice
·
146
PDF
CrystalCMP : an easy-to-use tool for fast comparison of molecular packing
2016
·
Jan Rohlíček
, Eliška Skořepová
, et al.
·
Journal of Applied Crystallography
·
114
Basic and clinical aspects of antimuscarinic agents used to treat overactive bladder
2018
·
Shizuo Yamada
, Yoshihiko Ito
, et al.
·
Pharmacology & Therapeutics
·
110
Benefits and Harms of Pharmacologic Treatment for Urinary Incontinence in Women: A Systematic Review
2012
·
Tatyana Shamliyan
, Jean F. Wyman
, et al.
·
Annals of Internal Medicine
·
108
Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage
2006
·
M. Horstmann
, T. Schaefer
, et al.
·
Neurourology and Urodynamics
·
106
Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways
2005
·
YongTae Kim
, Naoki Yoshimura
, et al.
·
Urology
·
106
Antimuscarinic Drugs: Review of the Cognitive Impact When Used to Treat Overactive Bladder in Elderly Patients
2011
·
Dustin Pagoria
, R. Corey O’Connor
, et al.
·
Current Urology Reports
·
88
Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia
2022
·
Christoph U. Correll
, Angel S. Angelov
, et al.
·
Schizophrenia
·
86
PDF
Management of Overactive Bladder and Urge Urinary Incontinence in the Elderly Patient
2006
·
Nurum Erdem
, Franklin M. Chu
·
The American Journal of Medicine
·
73
Evidence of trospium’s ability to mitigate cholinergic adverse events related to xanomeline: phase 1 study results
2023
·
Alan Breier
, Stephen K. Brannan
, et al.
·
Psychopharmacology
·
72
PDF
Overactive Bladder Drugs and Constipation: A Meta-Analysis of Randomized, Placebo-Controlled Trials
2010
·
Patrick D. Meek
, Samuel D. Evang
, et al.
·
Digestive Diseases and Sciences
·
71
Pharmacoeconomic Evaluation of Antimuscarinic Agents for the Treatment of Overactive Bladder
2006
·
Yu Ko
, Daniel C. Malone
, et al.
·
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
·
70
Agents for Treatment of Overactive Bladder: A Therapeutic Class Review
2007
·
Kristen Hesch
·
Baylor University Medical Center Proceedings
·
65
A systematic review of neurocognitive dysfunction with overactive bladder medications
2021
·
Vi Duong
, Aya Iwamoto
, et al.
·
International Urogynecology Journal
·
63
Treatment of the overactive bladder syndrome with muscarinic receptor antagonists - a matter of metabolites?
2006
·
Martin C. Michel
, Sharath S. Hegde
·
Naunyn-Schmiedeberg s Archives of Pharmacology
·
61
Show more works
View as search
Works count:
294
Citation count:
7,177
Year
Topic
Type